At Sanofi Genzyme, treating specialty conditions like Hemophilia A and Hemophilia B isn’t just what we do—it’s who we are. It’s why we do everything we can to make a difference in the lives of patients, caregivers, and physicians. Why we strive to research, develop, and discover groundbreaking advancements. Why we use our global scale to create a true, lasting difference. From pipeline to patients, we know that our commitment has the potential to truly transform. Click www.rareblooddisorders.com to learn more.